we studied clinical and immunologic aspects of the reactions to two newly introduced drugs , chymopapain and human recombinant deoxyribonucleic acid insulin ( hi ) , in patients demonstrating allergies to one of these two drugs .
C0795635
human recombinant
C0013182
allergies to